{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:58:30Z","timestamp":1781107110692,"version":"3.54.1"},"reference-count":45,"publisher":"National Academy of Sciences","issue":"25","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[1997,12,9]]},"abstract":"<jats:p>\n                    A recombinant adeno-associated virus (rAAV) vector capable of infecting cells and expressing rat glial cell line-derived neurotrophic factor (rGDNF), a putative central nervous system dopaminergic survival factor, under the control of a potent cytomegalovirus (CMV) immediate\/early promoter (AAV-MD-rGDNF) was constructed. Two experiments were performed to evaluate the time course of expression of rAAV-mediated GDNF protein expression and to test the vector in an animal model of Parkinson\u2019s disease. To evaluate the ability of rAAV-rGDNF to protect nigral dopaminergic neurons in the progressive Sauer and Oertel 6-hydroxydopamine (6-OHDA) lesion model, rats received perinigral injections of either rAAV-rGDNF virus or rAAV-\n                    <jats:italic>lacZ<\/jats:italic>\n                    control virus 3 weeks prior to a striatal 6-OHDA lesion and were sacrificed 4 weeks after 6-OHDA. Cell counts of back-labeled fluorogold-positive neurons in the substantia nigra revealed that rAAV-MD-rGDNF protected a significant number of cells when compared with cell counts of rAAV-CMV-\n                    <jats:italic>lacZ<\/jats:italic>\n                    -injected rats (94% vs. 51%, respectively). In close agreement, 85% of tyrosine hydroxylase-positive cells remained in the nigral rAAV-MD-rGDNF group vs. only 49% in the\n                    <jats:italic>lacZ<\/jats:italic>\n                    group. A separate group of rats were given identical perinigral virus injections and were sacrificed at 3 and 10 weeks after surgery. Nigral GDNF protein expression remained relatively stable over the 10 weeks investigated. These data indicate that the use of rAAV, a noncytopathic viral vector, can promote delivery of functional levels of GDNF in a degenerative model of Parkinson\u2019s disease.\n                  <\/jats:p>","DOI":"10.1073\/pnas.94.25.14083","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T10:35:50Z","timestamp":1027679750000},"page":"14083-14088","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":268,"title":["Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson\u2019s disease\u2009in\u2009rats"],"prefix":"10.1073","volume":"94","author":[{"given":"R. J.","family":"Mandel","sequence":"first","affiliation":[{"name":"Department of Gene Therapy Applications, Cell Genesys Inc., 342 Lakeside Drive, Foster City, CA 94404"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. K.","family":"Spratt","sequence":"additional","affiliation":[{"name":"Department of Gene Therapy Applications, Cell Genesys Inc., 342 Lakeside Drive, Foster City, CA 94404"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. O.","family":"Snyder","sequence":"additional","affiliation":[{"name":"Department of Gene Therapy Applications, Cell Genesys Inc., 342 Lakeside Drive, Foster City, CA 94404"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"Leff","sequence":"additional","affiliation":[{"name":"Department of Gene Therapy Applications, Cell Genesys Inc., 342 Lakeside Drive, Foster City, CA 94404"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[1997,12,9]]},"reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.66010074.x"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199512000-00035"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)01366-P"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90218-6"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199601310-00060"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/cne.903550402"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(96)12729-4"},{"key":"e_1_3_2_8_2","first-page":"348","volume":"7","author":"Opacka-Juffry J","year":"1995","unstructured":"J Opacka-Juffry, S Ashworth, S P Hume, D Martin, D J Brooks, S B Blunt Neuroreport 7, 348\u2013352 (1995).","journal-title":"Neuroreport"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.19.8935"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(94)00224-O"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/380252a0"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/382080a0"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81311-2"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-3806(94)00197-8"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(96)13265-1"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(96)01265-6"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5301.838"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.16.8818"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(89)80002-8"},{"key":"e_1_3_2_20_2","first-page":"303","volume":"49","author":"Venero J L","year":"1996","unstructured":"J L Venero, F Hefti, B Knusel Mol Pharmacol 49, 303\u2013310 (1996).","journal-title":"Mol Pharmacol"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)90605-X"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-22-07206.1996"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.266.5189.1399"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1094-148"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199412300-00014"},{"key":"e_1_3_2_26_2","first-page":"97","volume":"158","author":"Muzyczka N","year":"1992","unstructured":"N Muzyczka Curr Top Microbiol Immunol 158, 97\u2013129 (1992).","journal-title":"Curr Top Microbiol Immunol"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.10.4407"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.4.2004-2015.1995"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.5.1401"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0797-270"},{"key":"e_1_3_2_31_2","first-page":"292","volume":"3","author":"During M J","year":"1996","unstructured":"M J During, P Leone Clin Neurosci 3, 292\u2013300 (1996).","journal-title":"Clin Neurosci"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)01488-8"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5259.263"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8493557"},{"key":"e_1_3_2_35_2","first-page":"170","volume":"167","author":"Springer J E","year":"1994","unstructured":"J E Springer, X Mu, L W Bergmann, J Q Trojanowski Exp Neurol 167, 170 (1994).","journal-title":"Exp Neurol"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.9.3822-3828.1989"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.7.5236-5243.1997"},{"key":"e_1_3_2_38_2","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos G","year":"1987","unstructured":"G Paxinos, C Watson The Rat Brain in Stereotaxic Coordinates (Academic, San Diego, CA, 1987)."},{"key":"e_1_3_2_39_2","first-page":"652","volume":"19","author":"Hudson J","year":"1993","unstructured":"J Hudson, A C Granholm, G Gerhardt, A Hoffman, P Biddle, N S Leela, F Collins, B Hoffer Soc Neurosci Abst 19, 652 (1993).","journal-title":"Soc Neurosci Abst"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/18.5.315"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1996.6401"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.9.6641-6649.1997"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.12.5547"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.8.3346"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0996-1028"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.94.25.14083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T14:56:13Z","timestamp":1649861773000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.94.25.14083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12,9]]},"references-count":45,"journal-issue":{"issue":"25","published-print":{"date-parts":[[1997,12,9]]}},"alternative-id":["10.1073\/pnas.94.25.14083"],"URL":"https:\/\/doi.org\/10.1073\/pnas.94.25.14083","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,12,9]]},"assertion":[{"value":"1997-08-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-12-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}